降低肺动脉压联合无创辅助通气治疗肺心病的疗效分析

袁怀军

（陕西省宝鸡市眉县中医医院，陕西 宝鸡，722300）

浏览次数：64次 下载次数：323次

摘要：

目的 探讨降低肺动脉压联合无创辅助通气治疗肺心病的疗效。方法 抽取我院2010年1月至2015年12月收治的肺心病患者36 例为研究对象，按照入院顺序将其分为对照组与联合组，各18 例。对照组采用降低肺动脉压治疗，联合组在对 照组的基础上采用无创辅助通气治疗，比较两组的治疗效果。结果 治疗前，两组PAP、LVEF、CO 水平比较，差异均无统计学 意义（P>0.05）；治疗后，两组PAP、LVEF、CO水平均优于治疗前，且联合组优于对照组（P<0.05）。联合组的治疗总有效率明显 高于对照组（P<0.05）。结论 降低肺动脉压联合无创辅助通气治疗肺心病疗效确切，值得推广。

关键词：肺心病；降低肺动脉压；无创辅助通气

中图分类号：R541.5文献标志码：A文章编号：2096-1413(2017)33-0091-02

Effect analysis of lower pulmonary artery pressure combined with noninvasive adjuvant ventilation therapy on

pulmonary heart disease
YUAN Huai-jun
(Mei County Traditional Chinese Medicine Hospital, Baoji 722300, China)

ABSTRACT: Objective To discuss the effect of lower pulmonary artery pressure combined with noninvasive adjuvant ventilation therapy on pulmonary heart disease. Methods A total of 36 patients with pulmonary heart disease in our hospital from January 2010 to December 2015 were enrolled in this study, and divided into the control group and the combined group, with 18 cases in each group. The control group was treated with lower pulmonary artery pressure, while the combined group was treated with noninvasive adjuvant ventilation therapy on the basis of the control group. The treatment effects in the two groups were compared. Results Before trement, there were no differences in the levels of PAP, LVEF and CO between the two groups (P>0.05). After treatment, the levels of PAP, LVEF and CO in the two groups were better than those before treatment, and those of the combined group were better than the control group (P<0.05). The total effective rate of the combined group was obviously higher than that of the control group (P<0.05). Conclusion The lower pulmonary artery pressure combined with noninvasive adjuvant ventilation therapy on pulmonary heart disease has remarkable effect, which is worthy of promotion.
KEYWORDS: pulmonary heart disease; lower pulmonary artery pressure; noninvasive adjuvant ventilation therapy

参考文献：
[1] 杨冬梅.降低肺动脉压与无创辅助通气联合治疗肺心病的研究[J]. 航空航天医学杂志,2015,26(2):177-178.
[2] 刘惠卿,李艳丽.无创呼吸机辅助通气治疗肺心病伴呼吸衰竭的临床观察[J].中国保健营养(中旬刊),2014,24(4):2117-2118.
[3] PAONE G,CONTI V,BIONDIZOCCAI G,et al.Long-term home noninvasive mechanical ventilation increases systemic inflammatory response in chronic obstructive pulmonary disease: a prospective observational study[J].Mediators Inflamm,2014,23(22):503145.
[4] 吕侯强,谢轩,杨丛丽,等.无创辅助通气联合米力农治疗COPD 急性加重期合并肺心病心力衰竭的临床效果观察[J].临床合理用药杂 志,2014,7(25):78-79.
[5] 赖蓉,李多,兰四友,等.法舒地尔联合无创正压通气治疗慢性肺源性心脏病急性加重的临床价值[J].中国现代医学杂志,2016,28(2):55-59.
[6] 杨博,靳伟.丹参川芎嗪联合无创双水平气道正压通气对矽肺并肺心病患者右心功能的疗效观察[J].实用中西医结合临床,2015,15(4):13-14.
[7] 康剑云,王小强.阿托伐他汀联合BiPAP 无创通气治疗AECOPD 合并慢性肺心病患者的临床研究[J].河北医药,2014,43(24):3769-3770.
[8] 吕侯强,谢轩,杨丛丽,等.无创辅助通气联合米力农对COPD 急性加重期合并肺心病心力衰竭患者NT-proBNP、hs-CRP 水平的影响 [J].临床合理用药杂志,2014,7(31):92-93.